Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00837421 · ClinicalTrials.gov registry record

The Ohio State University Sepsis Registry

A clinical trial, sponsored by Ohio State University.

Terminated
Registry status
230
Enrollment target

NCT00837421 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 230 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00837421 was terminated before completion, sponsored by Ohio State University.

TERMINATED
Registry status
230 participants
Enrollment target

Study Summary

Specific Aim #1: To collect follow-up information about patients with sepsis in the OSUMC MICU who survive to hospital discharge for future retrospective IRB-approved studies. Specific Aim #2: To collect a registry of patients who would be interested in hearing more information about future prospective IRB-approved studies for survivors of sepsis. Specific Aim #3: To collect a blood sample from patients with sepsis admitted to the OSUMC MICU for future retrospective IRB-approved studies.

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2006-12
Est. Completion 2011-11

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT00837421

The ClinicalTrials.gov registry entry for NCT00837421 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00837421 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00837421 about?

NCT00837421 is a clinical study titled "The Ohio State University Sepsis Registry". Specific Aim #1: To collect follow-up information about patients with sepsis in the OSUMC MICU who survive to hospital discharge for future retrospective IRB-approved studies. Specific Aim #2: To collect a registry of patients who would be interested in hearing more information about future prospec...

What is the current status of trial NCT00837421?

This trial is currently terminated. The enrollment target is 230 participants. The study started on 2006-12. Estimated completion is 2011-11.

Who is sponsoring clinical trial NCT00837421?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.